| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 71.70B | 71.20B | 71.67B | 69.79B | 59.44B | 55.81B |
| Gross Profit | 14.97B | 14.76B | 15.04B | 14.43B | 14.73B | 14.00B |
| EBITDA | 3.30B | 3.15B | 3.52B | 1.42B | 1.79B | 1.44B |
| Net Income | 28.00M | -29.00M | 3.22B | -1.10B | 388.00M | 950.00M |
Balance Sheet | ||||||
| Total Assets | 88.43B | 88.71B | 96.12B | 92.98B | 88.85B | 80.67B |
| Cash, Cash Equivalents and Short-Term Investments | 7.12B | 8.74B | 13.42B | 6.95B | 6.60B | 9.32B |
| Total Debt | 24.30B | 24.52B | 25.33B | 26.60B | 24.28B | 16.68B |
| Total Liabilities | 46.93B | 46.92B | 53.30B | 53.45B | 47.05B | 38.46B |
| Stockholders Equity | 44.15B | 44.25B | 44.52B | 40.61B | 42.18B | 42.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.21B | 8.43B | -1.67B | -9.95B | -8.79B |
| Operating Cash Flow | 0.00 | -2.31B | 9.95B | 263.00M | 1.21B | 4.12B |
| Investing Cash Flow | 0.00 | -2.15B | -1.77B | -662.00M | -9.56B | -10.59B |
| Financing Cash Flow | 0.00 | -1.23B | -1.70B | 915.00M | 6.80B | 9.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥10.63B | 3.04 | ― | 1.66% | 8.56% | 2690.35% | |
76 Outperform | ¥181.90B | 11.81 | ― | 4.91% | 6.35% | 14.05% | |
75 Outperform | ¥34.53B | 3.81 | ― | 3.56% | 3.03% | 160.39% | |
72 Outperform | ¥176.24B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
66 Neutral | ¥9.51B | 3.19 | ― | 2.65% | 1.11% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
46 Neutral | ¥10.92B | 8.82 | ― | 4.41% | 2.78% | -88.37% |